Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.
Alex E. Roher(Barrow Neurological Institute), Melvyn J. Ball(Wayne State University), Heidi A. Zürcher-Neely(Wayne State University), Robert L. Heinrikson(Wayne State University), R. Wang(Wayne State University), Jonathan D. Lowenson(Wayne State University), Robert J. Cotter(Wayne State University), Steven Clarke(University of California, Los Angeles), Cathy Wolkow(Wayne State University), Ilene M. Reardon(Wayne State University)
Cited by 799
Related Papers
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
|American Journal Of Pathology|1999|1.5k
beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.
|Proceedings of the National Academy of Sciences|1993|742
Cerebral Amyloid Angiopathy
|American Journal Of Pathology|1998|682
Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains
|Journal of Biological Chemistry|1996|616